Local Uxbridge MP and Foreign Secretary, Boris Johnson, and leader of Hillingdon Council, Raymond Puddifoot, have officially opened TraceLink’s new European headquarters in Uxbridge.
The move will enable TraceLink Inc., a life sciences technology firm which has its US headquarters in Massachusetts, to create roles for 55 new employees at its European headquarters in Uxbridge across sales, services, marketing and administration during 2017, more than doubling its workforce in the UK.
Forming part of a £55 million investment into its overall global operations this year, TraceLink also plans to expand its European team by more than 80 percent in the next twelve months as demand for its cloud network solution increases within the European pharmaceutical sector.
Tracelink has taken 8,500 sq ft in the Charter Building, a recently completed office building in Uxbridge developed by a partnership between Landid and Brockton Capital, for its new European HQ. The office is the company’s second largest site, with over 70 employees based out of the location. Other office locations include the US, India and Singapore.
Commenting on the investment Uxbridge MP and Foreign Secretary Boris Johnson said:”I am delighted to be here today to celebrate TraceLink’s continued success and decision to add further investment and jobs into the UK.
“In 2015 the UK life sciences sector contributed £30.4 billion in UK GDP, supported 482,000 jobs and contributed £8.6 billion in taxes. TraceLink’s decision to create substantial job growth and invest in its European headquarters adds yet further strength to the importance of the life sciences sector to the UK economy and is a real boost for the local communities. With an honorable mission to help the life sciences industry protect the global medicine supply, I am proud to have companies like TraceLink right here in Uxbridge to continue pushing the UK to the forefront of the global life sciences sector.
“The Government’s drive to improve UK healthcare outcomes can only be helped by the ongoing success of the UK life sciences sector and companies like TraceLink continuing to innovate in order to tackle global healthcare challenges.”
The company’s new headquarters will allow TraceLink to continue helping the life sciences industry meet new European regulations to protect against counterfeit medicines entering the supply chain and follows an impressive 656 percent growth in European sales bookings for Q1.
“By 2020, over 80 percent of the world’s prescription drugs will be covered by ‘track and trace’ laws to reduce the problem of counterfeit medicines; a challenge that involves massive amounts of data and a complex web of supply chain partners. Expanding our presence in Europe is a natural step due to the urgent demand we’ve seen from the region for our proven solution in meeting EU regulatory requirements, which come into force in 2019,” said Shabbir Dahod, president and CEO, TraceLink.
Leader of Hillingdon Council, Raymond Puddifoot said he welcomed the news. “I am delighted that TraceLink has chosen to invest in Uxbridge. New jobs bring increased stability and a real boost for the local economy, it’s great news for the area.”
Jean-Marie Aulnette, vice president, Europe, TraceLink added: “The Uxbridge site is an ideal location due to its close proximity to central London which means it benefits from great transport links. This is incredibly important for our employees, many of whom live in London and commute on a daily basis. We hope that the office, which is in an affordable and popular area, will attract new talent in the future as we look to expand the business. The new site provides us with the capacity to do this, while also helping to support the local economy.”
The development of the European team will be focused on continuing to build regional and native expertise, and expanding the 15 languages already spoken by the current TraceLink services team in EMEA. Worldwide, TraceLink expects to have over 400 employees by the end of 2017, an 80 percent year-over-year increase in global employee growth.
As part of its EU recruitment drive, the company has also added two regional EU sales leaders, deepening its pan-European presence to develop localised TraceLink teams dedicated to serving the life sciences industry in specific markets, including the DACH (Germany, Austria and Switzerland) region and Southern Europe.